And also if you have any thoughts on this: how large lp(a) siRNA manufacturing has to be in metric tons for peak sales period?

Good to see you here, Dirk. Any thoughts on commercial potential of Lilly vs Amgen/Arrowhead LP(a) siRNA molecules from frequency of administration perspective?